WST Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: April 30, 2026

Report Source: 2026 1st Quarter Report

West Pharmaceutical Services Inc

West Pharmaceutical Services Inc. Stock Analysis WST

United States Health Care Large Cap Report:
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,800 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Read More

West Pharmaceutical Services Inc (WST) Chart

Key Statistics of West Pharmaceutical Services Inc (WST)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$296.76$304.93

Today's Open

$296.76

Volume

686.42K

P/E Ratio (TTM)

43.59

52 Week Range

$202.79$330.88

Market Cap

19.13B

Avg. Volume

1.03M

Dividend Yield

0.29%

Financial Metrics & Statements of West Pharmaceutical Services Inc (WST)

Community-Curated Collections with West Pharmaceutical Services Inc (WST) ( With WST )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for West Pharmaceutical Services Inc (WST)

  • According to Musaffa’s Shariah screening methodology, West Pharmaceutical Services Inc (WST) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.